Characterization of community-acquired Clostridioides difficile strains in Israel, 2020–2022
Frontiers in Microbiology · 19.12.2023 · 14
DOI: 10.3389/fmicb.2023.1323257 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 19.12.2023. Verfasst von Orna Schwartz und 10 weiteren Autor:innen. Beteiligte Einrichtung: Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The prevalence of community-acquired Clostridioides difficile infection (CA-CDI) has been rising, due to changes in antibiotics prescribing practices, emergence of hypervirulent strains and improved diagnostics. This study explored CA-CDI epidemiology by examining strain diversity and virulence factors of CA-CDI isolates collected across several geographical regions in Israel.
Methods
Stool samples of 126 CA-CDI patients were subjected to PCR and an immunoassay to identify toxin genes and proteins, respectively. Toxin loci PaLoc and PaCdt were detected by whole-genome sequencing (WGS). Biofilm production was assessed by crystal violet-based assay. Minimum inhibitory concentration was determined using the Etest technique or agar dilution. WGS and multi-locus sequence typing (MLST) were used to classify strains and investigate genetic diversity.
Results
Sequence types (ST) 2 (17, 13.5%), ST42 (13, 10.3%), ST104 (10, 8%) and ST11 (9, 7.1%) were the most common. All (117, 92.8%) but ST11 belonged to Clade 1. No associations were found between ST and gender, geographic area or antibiotic susceptibility. Although all strains harbored toxins genes, 34 (27%) produced toxin A only, and 54 (42.9%) strains produced toxin B only; 38 (30.2%) produced both toxins. Most isolates were biofilm-producers (118, 93.6%), primarily weak producers (83/118, 70.3%). ST was significantly associated with both biofilm and toxin production.
Conclusion
C. difficile isolates in Israel community exhibit high ST diversity, with no dominant strain. Other factors may influence the clinical outcomes of CDI such as toxin production, antibiotic resistance and biofilm production. Further studies are needed to better understand the dynamics and influence of these factors on CA-CDI.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel.
- Clinical Microbiology Laboratory, The Edith Wolfson Medical Center, Holon, Israel.
- Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
- Clinical Microbiology Laboratory, Tzafon Medical Center, Poriya, Israel.
- Shamir Medical Center, Be'er Ya'akov, Israel.
- Infectious Diseases Unit, The Edith Wolfson Medical Center, Holon, Israel.
Zitieren
APA
Schwartz, O., Rohana, H., Azrad, M., Shor, A., Rainy, N., Maor, Y., Nesher, L., Sagi, O., Ken-Dror, S., Kechker, P., & Peretz, A. (2023). Characterization of community-acquired Clostridioides difficile strains in Israel, 2020–2022. Frontiers in Microbiology, 14. https://doi.org/10.3389/fmicb.2023.1323257
Vancouver
Schwartz O, Rohana H, Azrad M, Shor A, Rainy N, Maor Y, et al. Characterization of community-acquired Clostridioides difficile strains in Israel, 2020–2022. Frontiers in Microbiology. 2023;14. doi:10.3389/fmicb.2023.1323257
BibTeX
@article{Schwartz2023,
author = {Schwartz, Orna and Rohana, Hanan and Azrad, Maya and Shor, Anna and Rainy, Nir and Maor, Yasmin and Nesher, Lior and Sagi, Orli and Ken-Dror, Shifra and Kechker, Peter and Peretz, Avi},
title = {Characterization of community-acquired Clostridioides difficile strains in Israel, 2020–2022},
journal = {Frontiers in Microbiology},
year = {2023},
volume = {14},
doi = {10.3389/fmicb.2023.1323257}
}
EUVIMED